Results 21 to 30 of about 215,570 (267)
BMC Endocrine Disorders, 2020 Background Previous studies have suggested that patients with diabetes mellitus (DM) have higher prevalence of atherosclerotic cardiovascular disease (ASCVD), and plasma levels of free fatty acids (FFAs) are a useful marker for predicting ASCVD.
Ming-Hua Zhang +9 more
doaj +1 more source
Arquivos Brasileiros de Cardiologia, 2016 Lipoproteins constitute a set of proteins and lipids, organized to facilitate the transport of lipids through blood plasma. Elevated or decreased levels of these lipoproteins may be related to genetic alterations in 40% to 60% of cases.1 This fact explains why it is common to find lipid abnormalities in several members of the same family.
García-Giustiniani, Diego +1 more
openaire +4 more sources
Treatment of dyslipidemia [PDF]
F1000Prime Reports, 2014 Atherosclerotic cardiovascular disease (including coronary heart disease, stroke and peripheral arterial disease) is the leading cause of death globally. Abnormal blood lipids (dyslipidemia), smoking, and high blood pressure are responsible for more than 75% of cases.
Tonkin, Andrew, Byrnes, Allison
openaire +2 more sources
Lipids in Health and Disease, 2018 Background Although there have been many reports in the genetics of familial hypercholesterolemia (FH) worldwide, studies in regard of Chinese population are lacking.
Di Sun +13 more
doaj +1 more source
Novel findings in relation to multiple anti-atherosclerotic effects of XueZhiKang in humans
Chronic Diseases and Translational Medicine, 2018 Background: Previous studies have clearly demonstrated that XueZhiKang (XZK), an extract of cholestin, can decrease low-density lipoprotein cholesterol (LDL-C) and cardiovascular events. However, the mechanism of the effects of XZK on atherosclerosis (AS)
Rui-Xia Xu +14 more
doaj +1 more source
Frontiers in Public Health, 2023 ObjectivesThis study aimed to investigate the association between body mass index (BMI) and dyslipidemia and to explore the interaction between BMI and family history of dyslipidemia towards dyslipidemia in patients with type 2 diabetes.MethodsThis cross-
Xiang-Yu Chen +5 more
doaj +1 more source
The Effects of Obesity and Physical Activity on Dyslipidemia in Persons With Type 2 Diabetes [PDF]
The Asian Journal of Kinesiology, 2022 OBJECTIVES This study was conducted to examine the effect of obesity, and physical activity on the prevalence of dyslipidemia in persons with type 2 diabetes mellitus (T2DM). METHODS A cross-sectional, correlational design was used.
Yun-A Shin +3 more
doaj +1 more source
Kidney & Blood Pressure Research, 2023 Introduction: Immunoglobulin A nephropathy (IgAN) is one of the most common glomerulonephritic diseases in the world. Several lines of evidence have suggested that dyslipidemia is related to the disease progression and prognosis of IgAN.
Sidi Liu +5 more
doaj +1 more source
EBioMedicine, 2018 Background: Severe hypertriglyceridemia (SHTG, TG ≥5·65 mmol/L), a disease, usually resulting from a combination of genetic and environmental factors, may increase the risk of acute pancreatitis (AP).
Jing-Lu Jin +11 more
doaj +1 more source
The Journal of Clinical Endocrinology & Metabolism, 2007 Recently, considerable progress has been made in understanding the genetic basis of dyslipidemias and in studying the safety and efficacy of lipid-lowering drugs for coronary heart disease (CHD) prevention. Novel loci have been identified for monogenic hypercholesterolemia, such as low-density lipoprotein (LDL) receptor (LDLR)-associated protein ...
Abhimanyu, Garg, Vinaya, Simha
openaire +2 more sources